In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy
Authors
Keywords
Photodynamic-immunotherapy, CD8, T cell pre-activation, In vivo, T cell targeting, Immune checkpoint blockade, Sequential cancer immunotherapy
Journal
Nano Today
Volume 44, Issue -, Pages 101492
Publisher
Elsevier BV
Online
2022-04-22
DOI
10.1016/j.nantod.2022.101492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy
- (2021) Yingying Hu et al. CHINESE CHEMICAL LETTERS
- Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
- (2021) Qinjun Chen et al. Nano-Micro Letters
- NIR-light triggered dual-cascade targeting core-shell nanoparticles enhanced photodynamic therapy and immunotherapy
- (2021) Dengshuai Wei et al. Nano Today
- pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy
- (2020) Zhaoqing Shi et al. CHINESE CHEMICAL LETTERS
- A Biomimetic Nanogenerator of Reactive Nitrogen Species Based on Battlefield Transfer Strategy for Enhanced Immunotherapy
- (2020) Qianhua Feng et al. Small
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
- (2020) Qinjun Chen et al. Advanced Science
- Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot
- (2020) Zhaoting Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy
- (2020) Weijing Yang et al. Science Advances
- Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost
- (2020) Ruyi Zhou et al. Nano Today
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication
- (2018) Wen Song et al. ACS Nano
- Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer
- (2018) Guangbao Yang et al. NANO LETTERS
- Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy
- (2018) Keman Cheng et al. NANO LETTERS
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
- (2018) Quanyin Hu et al. Nature Biomedical Engineering
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
- (2017) Alice O. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
- (2017) Sean P. Arlauckas et al. Science Translational Medicine
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- Nanoparticles in Photodynamic Therapy
- (2015) Sasidharan Swarnalatha Lucky et al. CHEMICAL REVIEWS
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
- (2014) Loek J. Eggermont et al. TRENDS IN BIOTECHNOLOGY
- Tolerance and exhaustion: defining mechanisms of T cell dysfunction
- (2013) Andrea Schietinger et al. TRENDS IN IMMUNOLOGY
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now